An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Elimination
According to the social media company, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.
Digital Marketplace Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of slimming results, positive testimonials and detailed guides for mixing or administering at residence.
After minutes of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts display dark colored packages with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service stated it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially significant medical dangers”.
